Novelion Therapeutics Subsidiary Enters Into Term Loan Agreement and Novelion Provides Business Update
pharmaceutical investing Novelion Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
pharmaceutical investing Novelion Therapeutics Announces Sentencing of Subsidiary Aegerion Pharmaceuticals
QIMC Defines Multiple New Hydrogen Hot Zones in Nova Scotia, Reports Stronger Preliminary DDH-26-05 Hydrogen Readings and Triples 2026 Nova Scotia Exploration Program Across a 43-km District-Scale Corridor
